Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
10/28/2022* -- Results Q2 2023 -- 0.99 --
10/28/2022* 08:00 EST Earnings Call Q2 2023 -- -- --
08/04/2022 -- Results Q1 2023 1.25 1.06 17.97%
08/04/2022 08:00 EST Earnings Call Q1 2023 -- -- --
04/28/2022 -- Results Q4 2022 1.16 1.05 10.12%
04/28/2022 08:00 EST Earnings Call Q4 2022 -- -- --
02/03/2022 -- Results Q3 2022 1.13 0.97 16.30%
02/03/2022 08:00 EST Earnings Call Q3 2022 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 10/28/2022 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 08/04/2022
Beat/Miss Upgrade
Return Since 0.96%
Last FQE 06/30/2022
Next FQE 09/30/2022

Profile

Edit
Abiomed Inc provides temporary mechanical circulatory support devices that are primarily used by interventional cardiologists and heart surgeons. The firm's products are used for patients in need of hemodynamic support before, during, or after angioplasty and heart surgery procedures. Abiomed receives the majority of revenue from its Impella product portfolio, which includes percutaneous micro heart pumps with integration motors and sensors and percutaneous catheter-based axial flow pumps. Abiomed generates the majority of its revenue in the United States.
URL https://www.abiomed.com
Investor Relations URL https://investors.abiomed.com/
HQ State/Province Massachusetts
Sector Healthcare
Industry Medical Devices
Equity Style Mid Cap/Growth
Next Earnings Release Oct. 28, 2022 (est.)
Last Earnings Release Aug. 04, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
137.2%
24.81%
66.32%
73.44%
-47.52%
90.05%
10.79%
-17.85%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-8.98%
12.64%
9.23%
31.23%
6.62%
22.20%
-6.75%
1.88%
6.81%
-35.79%
-38.13%
-31.16%
-24.87%
108.1%
-27.93%
-13.82%
-0.44%
-7.59%
-78.57%
4.09%
-76.55%
-0.62%
-24.70%
-53.18%
-7.14%
-14.78%
-47.58%
48.46%
17.10%
-95.00%
-57.48%
77.60%
-36.04%
As of August 15, 2022.

Profile

Edit
Abiomed Inc provides temporary mechanical circulatory support devices that are primarily used by interventional cardiologists and heart surgeons. The firm's products are used for patients in need of hemodynamic support before, during, or after angioplasty and heart surgery procedures. Abiomed receives the majority of revenue from its Impella product portfolio, which includes percutaneous micro heart pumps with integration motors and sensors and percutaneous catheter-based axial flow pumps. Abiomed generates the majority of its revenue in the United States.
URL https://www.abiomed.com
Investor Relations URL https://investors.abiomed.com/
HQ State/Province Massachusetts
Sector Healthcare
Industry Medical Devices
Equity Style Mid Cap/Growth
Next Earnings Release Oct. 28, 2022 (est.)
Last Earnings Release Aug. 04, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
BCSIX 167.41M USD 4.26%
POAGX 189.00M USD 2.64%
POGRX 167.04M USD 2.36%
KONG 537304.0 USD 2.16%
DBMCX 49.95M USD 1.87%
RYH 16.11M USD 1.68%
WMGRX 91.73M USD 1.67%
HTEC 1.961M USD 1.54%
XHE 6.224M USD 1.34%
BMEZ 32.67M USD 1.29%
IHI 81.85M USD 1.17%
VWUSX 300.75M USD 0.93%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter ABMD Tweets